Mederi's Stretta Therapy for GERD Approved in China

News Mederi Therapeutics Inc. has announced regulatory approval by CFDA and product launch in China for Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). Contributed Author: PR Newswire Topics: Surgical